Recent Advances in Breast Cancer Imaging

Dear Colleagues,

We are delighted to extend an invitation for the submission of your cutting-edge original or review research papers on breast cancer imaging. As breast cancer remains one of the most prevalent and pressing health concerns globally, the significance of advanced imaging techniques in its detection, characterization, and treatment evaluation cannot be overstated. We welcome submissions exploring a wide array of topics, including the following:

• The development and optimization of novel imaging modalities such as magnetic resonance imaging (MRI), digital breast tomosynthesis (DBT), and contrast-enhanced mammography for early detection and risk stratification of breast lesions;
• Advancements in quantitative imaging biomarkers and artificial intelligence algorithms to improve diagnostic accuracy, prognostication, and treatment response assessment; elucidation of the role of imaging in guiding personalized treatment strategies, including neoadjuvant chemotherapy planning, surgical margin assessment, and post-treatment surveillance;
• Exploration of imaging-based techniques for assessing tumor heterogeneity, microenvironmental factors, and molecular subtypes to inform precision medicine approaches;
• The integration of multimodal imaging approaches to provide comprehensive insights into the complex biology of breast cancer progression and metastasis.

We also welcome machine learning analysis of breast images. Your contributions have the potential to revolutionize breast cancer care by enhancing early detection, optimizing treatment strategies, and improving patient outcomes.

Prof. Dr. Tim Duong
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• breast cancer
• neoadjuvant chemotherapy
• axillary lymph nodes
• molecular subtypes
• hormonal receptor positive
• medical oncology
• breast surgery
• breast cancer metastasis
• pathological complete response
• breast cancer recurrence